This picture is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license – Source

2016 ended very well for HCS Pharma, with a fundraising finalized with the regional funds of the French country “Hauts de France”. This fundraising allows us to settle a new location in Lille, closest to the researchers and clinicians of the centers of excellence on neurodegenerative diseases and oncology.  We already have collaborative research projects with these teams and we are going to strengthen it. Our team will also grow throughout the year with different recruitments planned. In the short run, the acquisition of a complete robotic platform will also be realized, to allow us to increase our throughput. If you want more information, feel free to contact us !


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

2017 : nouveaux horizons et nouvelles opportunités ! | Grégory MAUBON · January 21, 2017 at 10:50 am

[…] 2017, la partie biotech va encore prendre plus de place, suite à la levée de fond de HCS Pharma et notre implantation à Lille. Le travail à faire est énorme puisque nous repartons (presque) de […]

Leave a Reply